Whole-body fluorine-18 fluordeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma.

[1]  R. Connelly,et al.  Third national cancer survey: incidence data. , 1975, National Cancer Institute monograph.

[2]  J. Fraumeni,et al.  Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. , 1976, Journal of the National Cancer Institute.

[3]  L. Kurland,et al.  Incidence of uveal malignant melanoma in the resident population of Rochester and Olmsted County, Minnesota. , 1979, American journal of ophthalmology.

[4]  G. Lucignani,et al.  MRI, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma. , 1992, Journal of computer assisted tomography.

[5]  B. Hawkins,et al.  A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. , 1992, Archives of ophthalmology.

[6]  C. Shields,et al.  Diffuse choroidal melanoma. Clinical features predictive of metastasis. , 1996, Archives of ophthalmology.

[7]  A. Fischman.  Positron emission tomography in the clinical evaluation of metastatic cancer. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  F. Fazio,et al.  Glucose metabolism and pathological findings in uveal melanoma: preliminary results. , 1996, Nuclear medicine communications.

[9]  Paul Kinahan,et al.  Attenuation correction for a combined 3D PET/CT scanner. , 1998, Medical physics.

[10]  W. Holder,et al.  Effectiveness of positron emission tomography for the detection of melanoma metastases. , 1998, Annals of surgery.

[11]  Norbert Avril,et al.  Relevance of Positron Emission Tomography (PET) in Oncology , 1999, Strahlentherapie und Onkologie.

[12]  Ashutosh Kumar Singh,et al.  Combination of clinical factors predictive of growth of small choroidal melanocytic tumors. , 2000, Archives of ophthalmology.

[13]  Paul Kinahan,et al.  A combined PET/CT scanner for clinical oncology. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[14]  S. Reske,et al.  FDG-PET for clinical use , 2001, European Journal of Nuclear Medicine.

[15]  O. Hoekstra,et al.  Systematic review of the diagnostic accuracy of 18F‐fluorodeoxyglucose positron emission tomography in melanoma patients , 2001 .

[16]  S. Cherry,et al.  Combining anatomy and function: the path to true image fusion , 2001, European Radiology.